openPR Logo
Press release

The Global Insomnia Market: Trends, Drivers, and Future Outlook

04-21-2025 04:13 PM CET | Health & Medicine

Press release from: Allied Market Research

Insomnia Market:

Insomnia Market:

The global insomnia market, valued at $4.3 billion in 2020, is projected to grow at a CAGR of 3.9%, reaching $6.3 billion by 2030. Insomnia, a prevalent sleep disorder, affects millions worldwide, leading to difficulties in falling asleep, staying asleep, or experiencing restful sleep. This article delves into the market drivers, segmentation, emerging trends, and future opportunities shaping the insomnia industry.

Get a Sample Copy of this Report: https://www.alliedmarketresearch.com/request-sample/2373

Key Drivers of the Insomnia Market
The growth of the insomnia market is driven by multiple factors, including:
• Rising Prevalence of Sleep Disorders: Insomnia and related conditions such as sleep apnea and restless leg syndrome are increasingly common, fueling the demand for effective treatments.
• Mental Health Issues: Depression and anxiety are closely linked to insomnia. The World Health Organization (WHO) reports that approximately 280 million people globally suffer from depression, contributing to market growth.
• Chronic Diseases and Medication Side Effects: Conditions such as cancer, cardiovascular diseases, and neurological disorders often disrupt sleep, increasing the need for insomnia treatments.
• Work-Related Stress: Irregular work schedules, night shifts, and high-pressure jobs negatively impact sleep patterns, leading to a surge in insomnia cases.
• Advancements in Non-Pharmacological Therapies: Cognitive behavioral therapy (CBT), hypnotherapy, and meditation are gaining popularity as effective non-drug treatments.
• Technological Innovations: Smart sleep-tracking devices, mobile health apps, and wearable technology provide real-time sleep analysis, improving insomnia management.

Market Segmentation
The insomnia market is categorized based on therapy type and region:
By Therapy Type
• Non-Pharmacological Therapy
• Hypnotherapy
• Cognitive Behavioral Therapy (CBT)
• Medical Devices (e.g., CPAP machines, sleep aids)
• Other Therapies (e.g., yoga, meditation)
• Pharmacological Therapy
• Prescription Sleep Aids (e.g., sedatives, orexin receptor antagonists)
• Over-the-Counter (OTC) Sleep Aids (e.g., melatonin supplements, antihistamines)

By Region
• North America: Leading the market due to high insomnia prevalence, advanced healthcare infrastructure, and work-related stress.
• Europe: Experiencing growth due to rising awareness and adoption of sleep therapies.
• Asia-Pacific: Expected to register the highest CAGR (5.5%) due to an aging population, irregular work schedules, and increasing healthcare investments.
• LAMEA (Latin America, Middle East, and Africa): Steady market growth is driven by improved healthcare access and awareness campaigns.

Emerging Trends and Opportunities
Several trends are shaping the insomnia market:
• Product Innovations: New drug formulations and non-drug alternatives continue to enter the market. Eisai Co., Ltd. launched DAYVIGO (lemborexant) in June 2021 as an effective treatment for adult insomnia.
• Growing Demand for Non-Pharmacological Solutions: Concerns over medication side effects are driving interest in alternative treatments like yoga, meditation, and digital CBT solutions.
• Expansion of Sleep Clinics and Diagnostic Centers: Specialized centers help diagnose and treat sleep disorders more effectively, improving patient outcomes.
• Wearable Sleep Technology: Devices like smartwatches and fitness trackers now offer sleep-tracking features, enabling better self-monitoring and diagnosis.

Challenges in the Insomnia Market
Despite promising growth, several challenges hinder market expansion:
• Side Effects of Medications: Dependency risks and adverse effects of long-term drug use limit widespread adoption.
• High Costs: Premium sleep aids, therapies, and diagnostic services remain unaffordable for many individuals.
• Lack of Awareness: In many developing countries, knowledge about sleep disorders and available treatments remains limited.

Key Players in the Insomnia Market
Leading companies in the global insomnia market include:
• Minerva Neurosciences Inc.
• Currax Pharmaceuticals LLC
• Eisai Co., Ltd.
• Merck & Co., Inc.
• Pfizer Inc.
• Sanofi
• Takeda Pharmaceutical Company Ltd.
• Vanda Pharmaceuticals
• Viatris (Mylan NV)
• Zydus Cadila

Future Outlook
The insomnia market is set for steady growth, fueled by increasing awareness, technological advancements, and demand for effective treatments. The rise of non-pharmacological therapies and AI-driven sleep solutions will further transform the industry. Additionally, the Asia-Pacific region is poised to become a key growth hub, providing lucrative opportunities for market players.

Key Takeaways
• The global insomnia market is projected to reach $6.3 billion by 2030.
• Major drivers include mental health issues, chronic diseases, and work-related stress.
• Non-pharmacological therapies and sleep technology are gaining traction.
• North America leads the market, while Asia-Pacific is expected to grow at the highest rate.
• Challenges include medication side effects, high costs, and limited awareness.

By addressing these challenges and leveraging emerging trends, stakeholders in the insomnia market can unlock significant growth opportunities in the coming years.

Enquire Before Buying: https://www.alliedmarketresearch.com/purchase-enquiry/2373

Contact:

David Correa
United States
1209 Orange Street,
Corporation Trust Center,
Wilmington, New Castle,
Delaware 19801 USA.
Int'l: +1-503-894-6022
Toll Free: +1-800-792-5285
Fax: +1-800-792-5285
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com
Allied Market Research Blog: https://blog.alliedmarketresearch.com
Follow Us on | Facebook | LinkedIn | YouTube

About Us:

Allied Market Research (AMR) is a full-service market research and business consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides end-to-end solutions along with information, education, advocacy, and networking resources to SMEs and early-stage start-ups to bring excellence to their processes. In addition, we offer a nurturing environment required to develop and grow businesses, including business planning; virtual support; market intelligence; acquiring resources; and getting direct access to finance, suppliers, and other experts to boost the growth of businesses and entrepreneurs.

Our bundled and hassle-free business support systems are customized to meet the needs of SME consultants and industry leaders. Moreover, our large network of skilled consultants and experts help start-ups get the business on a roll.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release The Global Insomnia Market: Trends, Drivers, and Future Outlook here

News-ID: 3979905 • Views:

More Releases from Allied Market Research

Airport Biometric Service Market Reach USD 131.3 Billion by 2033 at 17.3% CAGR
Airport Biometric Service Market Reach USD 131.3 Billion by 2033 at 17.3% CAGR
Allied Market Research published a report, titled, "Airport Biometric Service Market by Scanner Type (Fingerprint Recognition, Facial Recognition, Iris Recognition, Palm Recognition, Signature Recognition, Voice Recognition and Others), and Deployment Mode (On-premises and Cloud): Global Opportunity Analysis and Industry Forecast, 2024-2033". According to the report, the airport biometric service market was valued at $26.1 billion in 2023, and is estimated to reach $131.3 billion by 2033, growing at a CAGR of
AI for Financial Services Market Reach USD 123.2 Billion by 2032 Globally
AI for Financial Services Market Reach USD 123.2 Billion by 2032 Globally
Allied Market Research published a report, titled, "AI for Financial Services Market by Component (Solution and Services), Application (Fraud Detection, Virtual Assistants, Business Analytics and Reporting, Quantitative and Asset Management, Customer Behavioral Analytics and Others): Global Opportunity Analysis and Industry Forecast, 2024-2032". According to the report, the ai for financial services market was valued at $13.7 billion in 2023, and is estimated to reach $123.2 billion by 2032, growing at a
Federated Learning Solutions Market Reach USD 301.9 Million by 2032 at 10.2% CAGR
Federated Learning Solutions Market Reach USD 301.9 Million by 2032 at 10.2% CAG …
Allied Market Research published a report, titled, "Federated Learning Solutions Market by Component (Solution and Services), Application (Drug Discovery, Data Privacy & Security Management, Risk Management, Shopping Experience Personalization, Industrial Internet of Things, Online Visual Object Detection and Others), and Industry Vertical (BFSI, Healthcare & Life Science, Retail & E-commerce, Manufacturing, Energy & Utilities and Others): Global Opportunity Analysis and Industry Forecast, 2024-2032". According to the report, the federated learning solutions
Next-Gen Biometric Authentication Market Reach USD 249.6 Billion by 2032 at 21.1% CAGR
Next-Gen Biometric Authentication Market Reach USD 249.6 Billion by 2032 at 21.1 …
Allied Market Research published a report, titled, "Next-Gen Biometric Authentication market by Component (Software and Service), by Technology (Fingerprint Recognition, Facial Recognition, Iris Recognition, Voice Recognition, Palm Vein Recognition, Signature Recognition and Others), Authentication Type (single-factor authentication and single-factor authentication), End User (Government, Defense, Travel and Immigration, Home Security, Banking and Financial Service, Healthcare and Others): Global Opportunity Analysis and Industry Forecast, 2024-2032". The next-gen biometric authentication market was valued at

All 5 Releases


More Releases for Insomnia

Global Insomnia Industry Analysis By Geography
Stratistics MRC's Insomnia Market report explains company profiling, key segments, market trends, top players and regional, country-level segments. Insomnia is a common sleep disorder characterized by difficulties in sleep. Insomnia can exist as alone or conjugated with other psychiatric problems. The exact reason for the cause of insomnia is still unknown. It is most common in women and the severity may increase in conditions like postpartum, menopause and pregnancy. Insomnia disorder
Competitive Analysis: Insomnia Market Behaviour 2017 - 2026
A recent study showed that nearly 20% people across the world are sleep-deprived, and this means that there will be more people in the coming years who could be victims of acute or chronic insomnia. This trend is sublime for players in the global insomnia market as there will be a larger audience to cater and of course, the need for producing alternative treatment methods to suit the varying needs
Mattress Sydney – Tips For Preventing Insomnia
Having insomnia? Sleeping on a quality mattress Sydney will improve your situation a lot. Insomnia is a condition in which you have a problem to fall asleep or after falling asleep, you have difficulty keeping that condition. However, it is not a disease, but a symptom. The concept of a good sleep generally differs from person to person. On average, an adult needs 7-8 hours of night sleep for normal functioning
Insomnia Market: Trends and Opportunities 2026
Global Insomnia Market: Brief Account The world insomnia market is envisaged to recoup promisingly from its drowsy growth in the past with a number of worthwhile and well-timed opportunities to take advantage of. Insomnia drugs could find an application in the treatment of Parkinson and Alzheimer’s disease as sedatives. The younger population can increase the global demand as intensively as the geriatric group with rising stress levels and persisting diseases
Insomnia Market Research Report 2026
Global Insomnia Market: Brief Account The world insomnia market is envisaged to recoup promisingly from its drowsy growth in the past with a number of worthwhile and well-timed opportunities to take advantage of. Insomnia drugs could find an application in the treatment of Parkinson and Alzheimer’s disease as sedatives. The younger population can increase the global demand as intensively as the geriatric group with rising stress levels and persisting diseases
Insomnia - US Drug Market: Rising Cases Of Insomnia To Be Biggest Driver
Insomnia is one of the common disorders affected to 35% of the worldwide population. Insomnia is primarily classified into primary and secondary subtypes. The number of people suffering from a sleep disorder, insomnia, is increasing in the United States. In the recent past, the launch of new products and drugs to treat insomnia has been benefiting the U.S. insomnia drugs market. The U.S. insomnia market is classified widely, which enables